Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1967 May;20(3):227–230. doi: 10.1136/jcp.20.3.227

Fibrinolytic components of human uterine arterial and venous blood

A V P Mackay 1, P C Das 1, P R Myerscough 1, J D Cash 1
PMCID: PMC473473  PMID: 5602553

Abstract

The fibrinolytic components of uterine arterial and venous blood were studied in 14 patients undergoing various obstetrical and gynaecological procedures. There was a highly significant higher concentration of plasminogen activator, as measured by the euglobulin lysis time, and fibrin degradation products in the uterine venous blood.

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Astrup T. Tissue activators of plasminogen. Fed Proc. 1966 Jan-Feb;25(1):42–51. [PubMed] [Google Scholar]
  3. BULUK K., FURMAN M. On the controlling function of the kidneys in fibrinolysis. Experientia. 1962 Mar 15;18:146–147. doi: 10.1007/BF02153867. [DOI] [PubMed] [Google Scholar]
  4. BULUK K., MALOFIEJEW M. OTRZYMYWANIE AKTYWATORA FIBRYNOLIZY W NERCE POZA USTROJEM (AKTYWATOR FIBRYNOLIZY W IZOLOWANEJ NERCE) Acta Physiol Pol. 1963 Jul-Aug;14:371–378. [PubMed] [Google Scholar]
  5. CHAKRABARTI R., BIRKS P. M., FEARNLEY G. R. Origin of blood fibrinolytic activity from veins and its bearing on the fate of venous thrombi. Lancet. 1963 Jun 15;1(7294):1288–1290. doi: 10.1016/s0140-6736(63)91984-6. [DOI] [PubMed] [Google Scholar]
  6. COCCHERI S., ASTRUP T. Thromboplastic and fibrinolytic activities of large human vessels. Proc Soc Exp Biol Med. 1961 Nov;108:369–372. doi: 10.3181/00379727-108-26941. [DOI] [PubMed] [Google Scholar]
  7. CUOCOLO R., ESPOSITO G., SPAMPINATO N. L'ATTIVIT'A FIBRINOLITICA EMATICA IN RAPPORTO ALL'ANESTESIA E ALL'INTERVENTO CHIRURGICO. Minerva Anestesiol. 1965 Apr;31:151–211. [PubMed] [Google Scholar]
  8. Cash J. D. Effect of moderate exercise on the fibrinolytic system in normal young men and women. Br Med J. 1966 Aug 27;2(5512):502–506. doi: 10.1136/bmj.2.5512.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GENTON E., KERN F., Jr, VON KAULLA K. Fibrinolysis induced by pressor amines. Am J Med. 1961 Oct;31:564–571. doi: 10.1016/0002-9343(61)90140-1. [DOI] [PubMed] [Google Scholar]
  10. Januszko T., Furman M., Buluk K. The kidneys and the liver as the organs regulating the fibrinolytic system of the circulating blood. Thromb Diath Haemorrh. 1966 May 15;15(3):554–560. [PubMed] [Google Scholar]
  11. KWAAN H. C., ASTRUP T. LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN THE EYE. Arch Pathol. 1963 Dec;76:595–601. [PubMed] [Google Scholar]
  12. KWAAN H. C., LO R., MCFADZEAN A. J. The production of plasma fibrinolytic activity in vivo by serotonin (5-hydroxytryptamine) creatinine sulphate. Clin Sci. 1957 May;16(2):255–259. [PubMed] [Google Scholar]
  13. MESSER D. L., CELANDER D. R., GUEST M. M. Stability of fibrin contiguous to intima of veins. Circ Res. 1962 Nov;11:832–837. doi: 10.1161/01.res.11.5.832. [DOI] [PubMed] [Google Scholar]
  14. Maki M., Nagayama M., Sasaki K., Yoneya T. A model of local fibrinolysis (marked elevation of fibrinolytic activity of blood obtained from vasa efferentia of the uterus). Tohoku J Exp Med. 1965 Jun 25;86(1):43–50. [PubMed] [Google Scholar]
  15. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  16. NUSSENZWEIG V., SELIGMANN M. [Analysis, by immuno-chemical methods, of the degradation by plasmin of human fibrinogen and fibrin, at different stages]. Nouv Rev Fr Hematol. 1960 Nov-Dec;15:451–466. [PubMed] [Google Scholar]
  17. Neri Serneri G. G., Rossi Ferrini P. L., Masotti G., Silvestrini E., Paoletti P., Nocentini P., Monaci M. Ricerche sull'influenza dei fattori vasculo-tessutali sulla coagulazione e sulla fibrinolisi. 8. Partecipazione della parete vasale all'attivazione del sistema fibrinolitico plasmatico provocata mediante somministrazione di adrenalina nel cane. G Gerontol. 1965 Jun;13(6):551–558. [PubMed] [Google Scholar]
  18. Niewiarowski S., Prokopowicz J., Poplawski A., Worowski K. Inhibition of dog fibrinolytic system in experimental tubular necrosis of kidney. Experientia. 1964 Feb 15;20(2):101–103. doi: 10.1007/BF02151267. [DOI] [PubMed] [Google Scholar]
  19. RASMUSSEN J., ROBERTS H. R., ASTRUP T. FIBRINOLYTIC ACTIVITY OF THE NORMAL AND FIBROMYOMATOUS HUMAN UTERUS. Surg Gynecol Obstet. 1964 Jun;118:1277–1280. [PubMed] [Google Scholar]
  20. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  21. REMMERT L. F., COHEN P. P. Partial purification and properties of a proteolytic enzyme of human serum. J Biol Chem. 1949 Nov;181(1):431–448. [PubMed] [Google Scholar]
  22. TODD A. S. The histological localisation of fibrinolysin activator. J Pathol Bacteriol. 1959 Jul;78:281–283. doi: 10.1002/path.1700780131. [DOI] [PubMed] [Google Scholar]
  23. Uszyński M., Januszko T., Uszyńska-Folejewska R., Buluk K. ZAWARTOś aktywatorà fibrynolizy w mieśniu macicy nieciezarnej i w czasie porodu. Ginekol Pol. 1965 Mar;36(3):315–318. [PubMed] [Google Scholar]
  24. WOROWSKI K., NIEWIAROWSKI S., PROKOPOWICZ J. FIBRINOLYSIS AND FIBRINOGEN BREAKDOWN PRODUCTS (ANTITHROMBIN VI) IN RENAL VENOUS BLOOD (RVB) IN DOG. Thromb Diath Haemorrh. 1964 Oct 15;12:87–104. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES